| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.01B | +23.8% |
| R&D Expense | $65.5M | +26.0% |
| SG&A Expense | $350.3M | +31.1% |
| Operating Income | $1.3M | -91.1% |
| Interest Expense | $33.2M | -27.2% |
| Pre-tax Income | -$43.0M | -47.2% |
| Income Tax | -$6.6M | -52.7% |
| Net Income | -$36.4M | -46.3% |
| EPS (Basic) | -$0.56 | -33.3% |
| EPS (Diluted) | -$0.56 | -33.3% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.6M | -47.6% |
| Accounts Receivable | $52.6M | +6.6% |
| Inventory | $211.0M | +34.3% |
| Current Assets | $339.3M | +15.6% |
| Total Assets | $1.54B | +2.9% |
| Current Liabilities | $151.8M | -11.1% |
| Long-term Debt | $449.3M | -28.8% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.4M | -147.4% |
| Capital Expenditures | $10.0M | -2.4% |
| Investing Cash Flow | -$37.4M | -290.8% |
| Financing Cash Flow | $31.8M | +393.1% |
| Free Cash Flow | -$40.4M | -174.9% |
| Total Liabilities |
| $792.1M |
| -10.0% |
| Stockholders' Equity | $748.0M | +21.2% |